21 items to benefit from health insurance as low-priced substitution dispensing drugs

Published: 2003-10-10 06:56:00

Updated: 2003-10-10 06:56:00

The Health Insurance Review Agency announced on October 7 that 53 items will be eligible for health insurance as their bioequivalence has been established and of these, 21 items is additionally classified as drugs eligible for low-priced substitution dispensing drugs.

Included in the 21 items are Hanmi Pharm's Atenolol tab./Sulpride tab., Chong Kun Dang Corporation's Cefaclor cap./Levopil ta...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.